Stay updated on Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial page.

Latest updates to the Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial page
- Check5 days agoChange DetectedA site-wide government funding status notice was added and the page revision updated from v3.4.0 to v3.4.1. No study content or core details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check13 days agoChange DetectedAdded UI/metadata updates: Show glossary, Revision: v3.4.0, and capitalization adjustments to No FEAR Act labels. These changes do not modify core study content, eligibility criteria, endpoints or patient-facing information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a Locations section with Maryland as the site and removed the Maryland Locations reference and the HHS Vulnerability Disclosure link in the prior revision.SummaryDifference0.2%

- Check76 days agoChange DetectedPublications section updated to indicate that entries are automatically filled from PubMed, and the revision version changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check84 days agoChange DetectedThe government funding notice banner warning of potential delays has been removed from the page, while the study details themselves remain unchanged.SummaryDifference0.4%

Stay in the know with updates to Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial page.